Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease. We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 × 10-8 with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 16% of the familial risk of this breast cancer subtype. There was high genetic correlation (0.72) between risk of ER-negative breast cancer and breast cancer risk for BRCA1 mutation carriers. These findings may lead to improved risk prediction and inform further fine-mapping and functional work to better understand the biological basis of ER-negative breast cancer.
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer / Milne RL; Kuchenbaecker KB; Michailidou K; Beesley J; Kar S; Lindström S; Hui S; Lemaçon A; Soucy P; Dennis J; Jiang X; Rostamianfar A; Finucane H; Bolla MK; McGuffog L; Wang Q; Aalfs CM; ABCTB Investigators; Adams M; Adlard J; Agata S; Ahmed S; Ahsan H; Aittomäki K; Al-Ejeh F; Allen J; Ambrosone CB; Amos CI; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Auber B; Auer PL; Ausems MGEM; Azzollini J; Bacot F; Balmaña J; Barile M; Barjhoux L; Barkardottir RB; Barrdahl M; Barnes D; Barrowdale D; Baynes C; Beckmann MW; Benitez J; Bermisheva M; Bernstein L; Bignon YJ; Blazer KR; Blok MJ; Blomqvist C; Blot W; Bobolis K; Boeckx B; Bogdanova NV; Bojesen A; Bojesen SE; Bonanni B; Børresen-Dale AL; Bozsik A; Bradbury AR; Brand JS; Brauch H; Brenner H; Bressac-de Paillerets B; Brewer C; Brinton L; Broberg P; Brooks-Wilson A; Brunet J; Brüning T; Burwinkel B; Buys SS; Byun J; Cai Q; Caldés T; Caligo MA; Campbell I; Canzian F; Caron O; Carracedo A; Carter BD; Castelao JE; Castera L; Caux-Moncoutier V; Chan SB; Chang-Claude J; Chanock SJ; Chen X; Cheng TD; Chiquette J; Christiansen H; Claes KBM; Clarke CL; Conner T; Conroy DM; Cook J; Cordina-Duverger E; Cornelissen S; Coupier I; Cox A; Cox DG; Cross SS; Cuk K; Cunningham JM; Czene K; Daly MB; Damiola F; Darabi H; Davidson R; De Leeneer K; Devilee P; Dicks E; Diez O; Ding YC; Ditsch N; Doheny KF; Domchek SM; Dorfling CM; Dörk T; Dos-Santos-Silva I; Dubois S; Dugué PA; Dumont M; Dunning AM; Durcan L; Dwek M; Dworniczak B; Eccles D; Eeles R; Ehrencrona H; Eilber U; Ejlertsen B; Ekici AB; Eliassen AH; EMBRACE; Engel C; Eriksson M; Fachal L; Faivre L; Fasching PA; Faust U; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Foulkes WD; Friedman E; Fritschi L; Frost D; Gabrielson M; Gaddam P; Gammon MD; Ganz PA; Gapstur SM; Garber J; Garcia-Barberan V; García-Sáenz JA; Gaudet MM; Gauthier-Villars M; Gehrig A; GEMO Study Collaborators; Georgoulias V; Gerdes AM; Giles GG; Glendon G; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Goodfellow P; Greene MH; Alnæs GIG; Grip M; Gronwald J; Grundy A; Gschwantler-Kaulich D; Guénel P; Guo Q; Haeberle L; Hahnen E; Haiman CA; Håkansson N; Hallberg E; Hamann U; Hamel N; Hankinson S; Hansen TVO; Harrington P; Hart SN; Hartikainen JM; Healey CS; HEBON; Hein A; Helbig S; Henderson A; Heyworth J; Hicks B; Hillemanns P; Hodgson S; Hogervorst FB; Hollestelle A; Hooning MJ; Hoover B; Hopper JL; Hu C; Huang G; Hulick PJ; Humphreys K; Hunter DJ; Imyanitov EN; Isaacs C; Iwasaki M; Izatt L; Jakubowska A; James P; Janavicius R; Janni W; Jensen UB; John EM; Johnson N; Jones K; Jones M; Jukkola-Vuorinen A; Kaaks R; Kabisch M; Kaczmarek K; Kang D; Kast K; kConFab/AOCS Investigators; Keeman R; Kerin MJ; Kets CM; Keupers M; Khan S; Khusnutdinova E; Kiiski JI; Kim SW; Knight JA; Konstantopoulou I; Kosma VM; Kristensen VN; Kruse TA; Kwong A; Lænkholm AV; Laitman Y; Lalloo F; Lambrechts D; Landsman K; Lasset C; Lazaro C; Le Marchand L; Lecarpentier J; Lee A; Lee E; Lee JW; Lee MH; Lejbkowicz F; Lesueur F; Li J; Lilyquist J; Lincoln A; Lindblom A; Lissowska J; Lo WY; Loibl S; Long J; Loud JT; Lubinski J; Luccarini C; Lush M; MacInnis RJ; Maishman T; Makalic E; Kostovska IM; Malone KE; Manoukian S; Manson JE; Margolin S; Martens JWM; Martinez ME; Matsuo K; Mavroudis D; Mazoyer S; McLean C; Meijers-Heijboer H; Menéndez P; Meyer J; Miao H; Miller A; Miller N; Mitchell G; Montagna M; Muir K; Mulligan AM; Mulot C; Nadesan S; Nathanson KL; NBSC Collaborators; Neuhausen SL; Nevanlinna H; Nevelsteen I; Niederacher D; Nielsen SF; Nordestgaard BG; Norman A; Nussbaum RL; Olah E; Olopade OI; Olson JE; Olswold C; Ong KR; Oosterwijk JC; Orr N; Osorio A; Pankratz VS; Papi L; Park-Simon TW; Paulsson-Karlsson Y; Lloyd R; Pedersen IS; Peissel B; Peixoto A; Perez JIA; Peterlongo P; Peto J; Pfeiler G; Phelan CM; Pinchev M; Plaseska-Karanfilska D; Poppe B; Porteous ME; Prentice R; Presneau N; Prokofieva D; Pugh E; Pujana MA; Pylkäs K; Rack B; Radice P; Rahman N; Rantala J; Rappaport-Fuerhauser C; Rennert G; Rennert HS; Rhenius V; Rhiem K; Richardson A; Rodriguez GC; Romero A; Romm J; Rookus MA; Rudolph A; Ruediger T; Saloustros E; Sanders J; Sandler DP; Sangrajrang S; Sawyer EJ; Schmidt DF; Schoemaker MJ; Schumacher F; Schürmann P; Schwentner L; Scott C; Scott RJ; Seal S; Senter L; Seynaeve C; Shah M; Sharma P; Shen CY; Sheng X; Shimelis H; Shrubsole MJ; Shu XO; Side LE; Singer CF; Sohn C; Southey MC; Spinelli JJ; Spurdle AB; Stegmaier C; Stoppa-Lyonnet D; Sukiennicki G; Surowy H; Sutter C; Swerdlow A; Szabo CI; Tamimi RM; Tan YY; Taylor JA; Tejada MI; Tengström M; Teo SH; Terry MB; Tessier DC; Teulé A; Thöne K; Thull DL; Tibiletti MG; Tihomirova L; Tischkowitz M; Toland AE; Tollenaar RAEM; Tomlinson I; Tong L; Torres D; Tranchant M; Truong T; Tucker K; Tung N; Tyrer J; Ulmer HU; Vachon C; van Asperen CJ; Van Den Berg D; van den Ouweland AMW; van Rensburg EJ; Varesco L; Varon-Mateeva R; Vega A; Viel A; Vijai J; Vincent D; Vollenweider J; Walker L; Wang Z; Wang-Gohrke S; Wappenschmidt B; Weinberg CR; Weitzel JN; Wendt C; Wesseling J; Whittemore AS; Wijnen JT; Willett W; Winqvist R; Wolk A; Wu AH; Xia L; Yang XR; Yannoukakos D; Zaffaroni D; Zheng W; Zhu B; Ziogas A; Ziv E; Zorn KK; Gago-Dominguez M; Mannermaa A; Olsson H; Teixeira MR; Stone J; Offit K; Ottini L; Park SK; Thomassen M; Hall P; Meindl A; Schmutzler RK; Droit A; Bader GD; Pharoah PDP; Couch FJ; Easton DF; Kraft P; Chenevix-Trench G; García-Closas M; Schmidt MK; Antoniou AC; Simard J.. - In: NATURE GENETICS. - ISSN 1061-4036. - STAMPA. - 49:(2017), pp. 1767-1778. [10.1038/ng.3785]
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.
Papi LMembro del Collaboration Group
;
2017
Abstract
Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease. We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 × 10-8 with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 16% of the familial risk of this breast cancer subtype. There was high genetic correlation (0.72) between risk of ER-negative breast cancer and breast cancer risk for BRCA1 mutation carriers. These findings may lead to improved risk prediction and inform further fine-mapping and functional work to better understand the biological basis of ER-negative breast cancer.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
